Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
ENTITY
SMARTSCORE: 2.6/5
GC Biopharma Corp (006280 KS)
Watchlist
98
Analysis
Health Care
•
South Korea
GC Biopharma is a biopharmaceutical company headquartered in Yongin, South Korea. It manufactures household medical drugs. The Company's product includes medicines for cold and fever, nutrition, antiseptic drug, and a lip balm.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Young Poong
•
01 Oct 2024 20:13
Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
525 Views
Share
bullish
•
Hyundai Mobis
•
01 Jul 2024 14:08
Korean Holdcos Vs Opcos Gap Trading Opportunities in 3Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
435 Views
Share
bearish
•
Quantitative Analysis
•
12 Jun 2024 02:10
KRX Short Interest Weekly (Jun 7th): Samsung Electronics
We analyzed KRX short interest report for the past week. We estimate the short interests were USD 6.1bn last week and highlighted short interest...
Ke Yan, CFA, FRM
Follow
342 Views
Share
bullish
•
Quantitative Analysis
•
29 May 2024 03:29
KRX Short Interest Weekly (May 24th): Samsung Electronics
We analyzed KRX short interest report for the past week and highlighted short interest changes in Samsung Electronics, Samsung SDI, Samsung Electro...
Ke Yan, CFA, FRM
Follow
350 Views
Share
bearish
•
HDC Hyundai Development Co-Engineering & Construction
•
01 Apr 2024 12:39
Korean Holdcos Vs Opcos Gap Trading Opportunities in 2Q 2024
In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
506 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.52.6
x